€160.00
PNC-28 is a research peptide studied for its selective anti-cancer properties, inducing necrosis in cancer cells while sparing healthy cells, with potential tumor-suppressing effects.
✓ Fast delivery
✓ Premium quality
✓ 3th party tested
In Stock
CompareAt DN Research, you can confidently buy PNC-28 peptide with the assurance of fast shipping, secure payment, and expert support every step of the way. Our commitment to quality and transparency ensures that you receive the highest-grade peptide for your research needs.
PNC-28 is a synthetic peptide designed to mimic the mdm-2-binding domain of the p53 protein. This peptide includes a penetratin sequence that enhances its ability to penetrate cancer cells. Unlike many other cancer-targeting peptides, PNC-28 primarily induces necrosis in cancer cells rather than apoptosis, leading to their rapid destruction while sparing normal cells.
PNC-28 has been a subject of extensive research due to its ability to selectively target malignant cells, particularly in aggressive forms of cancer. It has shown potential in pancreatic cancer research, demonstrating the ability to inhibit tumor growth and selectively eliminate cancer cells.
Scientific studies have explored several potential applications of PNC-28 peptide, including:
PNC-28 has shown significant promise in cancer research due to its ability to selectively induce necrosis in cancer cells. Unlike chemotherapy, which often damages both cancerous and healthy cells, PNC-28 targets malignant cells through its interaction with hdm-2, a protein overexpressed in many types of cancer. This interaction leads to the formation of membrane pores, disrupting the integrity of cancer cells and causing their destruction.
Preclinical research indicates that PNC-28 may:
These findings suggest that PNC-28 could provide a new approach to cancer treatment, particularly for tumors resistant to traditional therapies.
PNC-28’s unique mechanism of action may offer benefits in tumor suppression. Research suggests that:
Because PNC-28 is independent of p53 status, it may have broad applications in treating various cancers, including pancreatic, lung, and colorectal malignancies.
Studies suggest that PNC-28 exerts its cytotoxic effects by:
These mechanisms make PNC-28 an attractive subject for further research in cancer therapy.
For researchers exploring novel cancer-targeting peptides, PNC-28 presents a promising area of study. Visit DN Research today to secure your supply of this innovative peptide.
This product is sold as a pure compound for research purposes only and is not meant for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.
Keep this product out of the reach of children. Limited research is available on its effects, and improper handling or consumption may lead to adverse effects. This product is intended for research use only and should only be handled by professionals with the proper knowledge and equipment. By purchasing this product, you agree to indemnify DN Research against any adverse effects resulting from misuse.
The information provided is for educational and research purposes only. This product is not a pharmaceutical or medication, and it has not been approved by the FDA for the treatment, prevention, or diagnosis of any disease or medical condition.